Increased Respiratory Viral Detection and Symptom Burden Among Patients with Primary Antibody Deficiency: Results from the BIPAD Study.

J Allergy Clin Immunol Pract · 2021 · PMC7442926 · PMID 32841749

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Specific patient subgroups showed a trend toward longer median SRE duration, notably those with CVID: 5 days (95% CI, 4-7 days) and bronchiectasis: 6 days (95% CI, 5-12 days).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.